In human DLBCL and FL, KMT2D aberrations are typically loss of function events, either leading to truncations or deleterious missense mutations within the SET domain, indicating that KMT2D acts as a tumor suppressor gene. The gene discussed is KMT2D; the disease is diffuse large B-cell lymphoma.